Hilltop Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,639
Closed -$336K 360
2017
Q3
$336K Buy
1,639
+214
+15% +$49.8K 0.1% 203
2017
Q2
$346K Buy
1,425
+73
+5% +$17.2K 0.1% 242
2017
Q1
$323K Buy
1,352
+20
+2% +$4.66K 0.1% 243
2016
Q4
$280K Sell
1,332
-123
-8% -$25.5K 0.09% 254
2016
Q3
$335K Buy
1,455
+69
+5% +$16.9K 0.11% 228
2016
Q2
$320K Buy
+1,386
New +$320K 0.1% 224
2016
Q1
Sell
-833
Closed -$260K 321
2015
Q4
$260K Buy
833
+18
+2% +$5.36K 0.08% 276
2015
Q3
$222K Sell
815
-475
-37% -$146K 0.06% 293
2015
Q2
$391K Buy
1,290
+274
+27% +$81.7K 0.11% 216
2015
Q1
$302K Buy
+1,016
New +$290K 0.08% 269

Other funds holding AGN

Hilltop Holdings's AGN Position: Q4 2017 in Review

Hilltop Holdings sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,639 shares — an estimated $336K sold.

Hilltop Holdings first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $391K in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Hilltop Holdings reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Hilltop Holdings sold 1,639 Allergan plc shares in Q4 2017, an estimated $336K.
  • Hilltop Holdings first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
  • Hilltop Holdings's Allergan plc position peaked at $391K in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Hilltop Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.